Cargando…

Successful combined umbilical cord blood and bone marrow transplantation from an HLA-matched sibling for MPS VI: a case report

Mucopolysaccharidosis type VI (MPS VI), also known as Maroteaux–Lamy syndrome, polydystrophic dwarfism, and arysulfatase B (ASB) deficiency, is a lysosomal storage disorder with autosomal recessive inheritance characterized by progressive multisystem involved that causes many tissues and organs to e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haria, Pankti, Kedage, Vinayak, Dalvi, Pradnya, Sanghavi, Satyen, Chandran, Parvathi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032436/ https://www.ncbi.nlm.nih.gov/pubmed/37181074 http://dx.doi.org/10.1177/26330040231154283

Ejemplares similares

Mutations in ARSB in MPS VI patients in India
por: Mathew, Juby, et al.
Publicado: (2015)

The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia
por: Brunstein, Claudio, et al.
Publicado: (2017)

Diagnostic difficulties in patients with attenuated form of MPS VI
por: Opoka – Winiarska, V, et al.
Publicado: (2011)

Reduction of lysosome abundance and GAG accumulation after odiparcil treatment in MPS I and MPS VI models
por: Tuyaa-Boustugue, Pascale, et al.
Publicado: (2023)

Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants
por: Gaziev, D, et al.
Publicado: (2000)

Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme(®)) therapy
por: Koseoglu, Selim T., et al.
Publicado: (2008)

Addressing the need for patient-friendly medical communications: adaptation of the 2019 recommendations for the management of MPS VI and MPS IVA
por: Bruce, Iain A., et al.
Publicado: (2022)

Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the ARSB gene
por: Tomanin, Rosella, et al.
Publicado: (2018)

Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance
por: Akyol, Mehmet Umut, et al.
Publicado: (2019)

Hidden genomic MHC disparity between HLA-matched sibling pairs in hematopoietic stem cell transplantation
por: Koskela, Satu, et al.
Publicado: (2018)

Sibling umbilical cord blood infusion is safe in young children with cerebral palsy
por: Sun, Jessica M., et al.
Publicado: (2021)

Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I
por: Azario, Isabella, et al.
Publicado: (2017)

A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients
por: Lu, Wenyi, et al.
Publicado: (2022)

PB2188: APPLICATION PROSPECT OF LOW DOSE PORCINE ANTITHYMOCYTE GLOBULIN IN HLA MATCHED SIBLING DONOR TRANSPLANTATION
por: chen, X., et al.
Publicado: (2022)

Cancers after HLA-matched related Bone Marrow Transplantation for Aplastic Anemia
por: Vo, Phuong, et al.
Publicado: (2021)

Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation
por: Iwasaki, Makoto, et al.
Publicado: (2022)

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GVHD?
por: Gallo, Susanna, et al.
Publicado: (2016)

Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
por: Williams, Louis, et al.
Publicado: (2020)

First experience of hematopoietic stem cell transplantation treatment of Shwachman–Diamond syndrome using unaffected HLA–matched sibling donor produced through preimplantation HLA typing
por: Isaev, A A, et al.
Publicado: (2017)

HLA-matched sibling transplantation with G-CSF mobilized PBSCs and BM decreases GVHD in adult patients with severe aplastic anemia
por: Zi-Min, Sun, et al.
Publicado: (2010)

Occurrence and Impact of Minor Histocompatibility Antigens' Disparities on Outcomes of Hematopoietic Stem Cell Transplantation from HLA-Matched Sibling Donors
por: Dzierzak-Mietla, Monika, et al.
Publicado: (2012)

Study protocol: Phase I/II trial of induced HLA-G(+) regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor
por: Lysandrou, Memnon, et al.
Publicado: (2023)

Association of HLA-G Low Expressor Genotype with Severe Acute Graft-Versus-Host Disease after Sibling Bone Marrow Transplantation
por: Boukouaci, Wahid, et al.
Publicado: (2011)

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
por: Ruggeri, Annalisa, et al.
Publicado: (2018)

India's First Child using PGT-M, PGT-A and HLA Matching for Helping a Sibling having β-Thalassemia Major
por: Banker, Jwal M., et al.
Publicado: (2019)

Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT
por: Raj, Kavita, et al.
Publicado: (2022)

Mucopolysaccharidosis: Cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI
por: Brands, Marion M. M. G., et al.
Publicado: (2012)

Improving the Estimation of Celiac Disease Sibling Risk by Non-HLA Genes
por: Izzo, Valentina, et al.
Publicado: (2011)

Allogeneic hematopoietic stem cell transplantation from non-sibling 10/10 HLA-matched related donors: a single-center experience
por: Shen, Yaoyao, et al.
Publicado: (2021)

Unrelated cord blood transplantation vs. HLA-matched sibling transplantation for adults with B-cell acute lymphoblastic leukemia in complete remission: superior OS for patients with long-term survival
por: Sun, Guangyu, et al.
Publicado: (2022)

A Generic Assay to Detect Aberrant ARSB Splicing and mRNA Degradation for the Molecular Diagnosis of MPS VI
por: Broeders, Mike, et al.
Publicado: (2020)

S274: A NEW, EFFECTIVE, SAFE, NON-MYELOABLATIVE CONDITIONING REGIMEN WITH A HLA-MATCHED SIBLING DONOR FOR THE SEVERE SICKLE CELL PHENOTYPE IN ADULTS
por: Ihlem, Rahal, et al.
Publicado: (2023)

α-Tocopherol Stereoisomer Profiles in Matched Human Maternal and Umbilical Cord Plasma
por: Kuchan, Matthew J, et al.
Publicado: (2021)

Analysis of the Influence of HLA-A Matching Relative to HLA-B and -DR Matching on Heart Transplant Outcomes
por: Ansari, David, et al.
Publicado: (2015)

Differences in MPS I and MPS II Disease Manifestations
por: Hampe, Christiane S., et al.
Publicado: (2021)

Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis
por: Robin, Marie, et al.
Publicado: (2019)

Disease burden, management patterns and multidisciplinary clinical approaches for patients with MPS IVA and VI in selected Latin American Countries
por: Solano, Villarreal M, et al.
Publicado: (2021)

Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data
por: Yu, Sijian, et al.
Publicado: (2020)

Hematopoietic stem cell transplantation from HLA-matched sibling donors in children with acute lymphoblastic leukemia: A report from the Children’s Cancer Hospital Egypt
por: Hammad, Mahmoud, et al.
Publicado: (2022)

Can PIRCHE-II Matching Outmatch Traditional HLA Matching?
por: Unterrainer, Christian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_26fp2gcmacq54v7jilpt1va9om